CLINICAL_TRIALS
trial_result
· 2023-10-30
Clinical Trial Update: The Effects of OC000459 on Nasal Mediators [Phase 1, Phase 2]
Summary
Phase 1/2 trial evaluating OC000459 for allergic rhinitis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Trevor Hansel | Conditions: Allergic Rhinitis | Phase 1, Phase 2 | Status: COMPLETED